AllenAJ, KurlanRM, GilbertDL, CoffeyBJ, LinderSL, LewisDW, WinnerPK, DunnDW, DureLS, SalleeFR, MiltonDR, MintzMI, RicardiRK, ErenbergG, LaytonLL, FeldmanPD, KelseyDK, SpencerTJ. Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology, 65:1941–1949. 2005.
2.
BlochMH, PanzaKE, Landeros-WeisenbergerA, LeckmanJF. Meta-analysis: Treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders. J Am Acad Child Adolesc Psychiatry, 48:884–893. 2009.
3.
Boon-yasidhiV, KimYS, ScahillL. An open-label, prospective study of guanfacine in children with ADHD and tic disorders. J Med Assoc Thai, 88:S156–S162. 2005.
Centers for Disease Control and Prevention. Prevalence of diagnosed Tourette syndrome in persons aged 6–17 years—United States. 2007. MMWR, 58:581–585. 2009.
6.
FreemanRD. for the Tourette Syndrome International Database Consortium. Tic disorders, ADHD: Answers from a world-wide clinical dataset on Tourette syndrome. Eur Child Adolesc Psychiatry, 16,Suppl 1:15–23. 2007Erratum in: Eur Child Adolesc Psychiatry 16:536, 2007.
7.
GadowKD, SverdJ, SprafkinJ, NolanEE, EnzorSN. Efficacy of methylphenidate for attention-deficit hyperactivity disorder in children with tic disorder. Arch Gen Psychiatry, 52:444–455. 1995.
8.
KhalifaN, Von KnorringAL. Prevalence of tic disorders and Tourette syndrome in a Swedish school population. Dev Med Child Neurol, 45:315–319. 2003.
9.
KhalifaN, Von KnorringAL. Psychopathology in a Swedish population of school children with tic disorders. J Am Acad Child Adolesc Psychiatry, 45:1346–1353. 2006.
10.
KurlanR. Methylphenidate to treat ADHD is not contraindicated in children with tics. Mov Disord, 17:5–6. 2002.
11.
LinazasoroG, Van BlercomN, de ZárateCO. Prevalence of tic disorder in two schools in the Basque country: Results and methodological caveats. Mov Disord, 21:106–109. 2006.
MasonS, BanerjeeV, Eapen, ZeitlinH, RobertsonMM. The prevalence of Tourette syndrome in a mainstream school population. Dev Med Child Neurol, 40:292–296. 1998.
14.
“Methylphenidate” Physicians' Desk Reference. 2013.
15.
PierreBC, NolanE, GadowK, SverdJ, SprafkinJ. Comparison of internalizing and externalizing symptoms in children with attention-deficit hyperactivity disorder with and without comorbid tic disorder. J Dev Behav Pediatr, 20:170–176. 1999.
16.
ScahillL, ErenbergG, Berlin JrCM, BudmanC, CoffeyBJ, JankovicJ, KiesslingL, KingRA, KurlanR, LangA, MinkJ, MurphyT, ZinnerS, WalkupJ. Tourette Syndrome Association Medical Advisory Board. Practice Committee. Contemporary assessment and pharmacotherapy of Tourette syndrome. NeuroRx, 3:192–206. 2006.
17.
SpencerT, BiedermanJ, WilensT. Attention-deficit/hyperactivity disorder and comorbidity. Ped Clin North Am, 46:915–927. 1999.
18.
SpencerT, BiedermanJ, HardingM, O'DonnellD, WilensT, FaraoneS, CoffeyB, GellerD. Disentangling the overlap between Tourette's disorder and ADHD. J Child Psychol Psychiatry, 39:1037–1044. 1998.
19.
SpencerTJ, SalleeFR, GilbertDL, DunnDW, McCrackenJT, CoffeyBJ, BudmanCL, RicardiRK, LeonardHL, AllenAJ, MiltonDR, FeldmanPD, KelseyDK, GellerDA, LinderSL, LewisDW, WinnerPK, KurlanRM, MintzM. Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome. J Atten Disord, 11:470–481. 2008.
20.
SteingardR, BiedermanJ, SpencerT, WilensT, GonzalezA. Comparison of clonidine response in the treatment of attention-deficit hyperactivity disorder with and without comorbid tic disorders. J Am Acad Child Adolesc Psychiatry, 32:350–353. 1993.
21.
Tourette's Syndrome Study Group. Treatment of ADHD in children with tics:. A randomized controlled trial. Neurology, 58:527–536. 2002.